 | • レポートコード：20QY06-08313 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、副鼻腔炎薬のグローバル市場について種類別（抗生物質、コルチコステロイド、充血除去剤）、用途別（急性副鼻腔炎、慢性副鼻腔炎）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・副鼻腔炎薬市場の概要 ・世界の主要地域別副鼻腔炎薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の副鼻腔炎薬市場規模2015-2026：種類別（抗生物質、コルチコステロイド、充血除去剤） ・世界の副鼻腔炎薬市場規模2015-2026：用途別（急性副鼻腔炎、慢性副鼻腔炎） ・副鼻腔炎薬の北米市場規模2015-2020 ・副鼻腔炎薬のヨーロッパ市場規模2015-2020 ・副鼻腔炎薬の中国市場規模2015-2020 ・副鼻腔炎薬の日本市場規模2015-2020 ・副鼻腔炎薬の東南アジア市場規模2015-2020 ・副鼻腔炎薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi、Bayer AG、Pfizer、AstraZeneca Plc、Novartis AG.、Johnson & Johnson、Merck、Amgen、Bionorica SE、Dr. Reddy's Laboratories、Huasun） ・副鼻腔炎薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・副鼻腔炎薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Drugs for Sinusitis Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Drugs for Sinusitis market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Sinusitis, also known as a sinus infection or rhinosinusitis, is inflammation of the sinuses resulting in symptoms. Common signs and symptoms include thick nasal mucus, a plugged nose, and pain in the face. Other signs and symptoms may include fever, headaches, poor sense of smell, sore throat, and cough. The cough is often worse at night. Serious complications are rare. It is defined as acute rhinosinusitis (ARS) if it lasts less than 4 weeks, and chronic rhinosinusitis (CRS) if it lasts for more than 12 weeks. Drugs for Sinusitis are common in the market, and the drugs can also be used in other disease. These drugs can not cure sinusitis, can only relieve symptoms.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Drugs for Sinusitis market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Drugs for Sinusitis industry.
Based on our recent survey, we have several different scenarios about the Drugs for Sinusitis YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2101.1 million in 2019. The market size of Drugs for Sinusitis will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Drugs for Sinusitis market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Drugs for Sinusitis market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Drugs for Sinusitis market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Drugs for Sinusitis market. The report also includes nautical information, where it shows Drugs for Sinusitis market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Drugs for Sinusitis market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Drugs for Sinusitis market.
The classification of Drugs for Sinusitis includes Antibiotics, Corticosteroids, Decongestants and other. And the revenue proportion of Corticosteroids in 2015 is nearly 31%.
Drugs for Sinusitis are widely used in Neurology, Orthopedics, Musculoskeletal &Spine, Cardiology & Vascular, Skin & Integumentary, and other field. The most proportion of Drugs for Sinusitis is Orthopedics, Musculoskeletal &Spine, and the revenue in 2015 is 2387.4 M USD.
North America region is the largest supplier of Drugs for Sinusitis, with a revenue market share nearly 35% in 2015. Europe is the second largest supplier of Drugs for Sinusitis, enjoying revenue market share nearly 27% in 2015.
North America is the largest consumption place, with a consumption market share nearly 35% in 2015. Following North America, Europe is the second largest consumption place with the consumption market share of 24%.
Sanofi, Bayer AG, Pfizer etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Geographical Analysis:
Based on region, the global Drugs for Sinusitis market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Drugs for Sinusitis market are
Sanofi
Bayer AG
Pfizer
AstraZeneca Plc
Novartis AG.
Johnson & Johnson
Merck
Amgen
Bionorica SE
Dr. Reddy’s Laboratories
Huasun
Segment by Type
Antibiotics
Corticosteroids
Decongestants
Segment by Application
Acute Sinusitis
Chronic Sinusitis
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Drugs for Sinusitis market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Drugs for Sinusitis market.
• The market share of the global Drugs for Sinusitis market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Drugs for Sinusitis market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Drugs for Sinusitis market.
1 Drugs for Sinusitis Market Overview
1.1 Drugs for Sinusitis Product Scope
1.2 Drugs for Sinusitis Segment by Type
1.2.1 Global Drugs for Sinusitis Sales by Type (2020-2026)
1.2.2 Antibiotics
1.2.3 Corticosteroids
1.2.4 Decongestants
1.3 Drugs for Sinusitis Segment by Application
1.3.1 Global Drugs for Sinusitis Sales Comparison by Application (2020-2026)
1.3.2 Acute Sinusitis
1.3.3 Chronic Sinusitis
1.4 Drugs for Sinusitis Market Estimates and Forecasts (2015-2026)
1.4.1 Global Drugs for Sinusitis Sales Growth Rate (2015-2026)
1.4.2 Global Drugs for Sinusitis Revenue and Growth Rate (2015-2026)
1.4.3 Global Drugs for Sinusitis Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Drugs for Sinusitis Industry Impact
1.5.1 How the Covid-19 is Affecting the Drugs for Sinusitis Industry
1.5.1.1 Drugs for Sinusitis Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Drugs for Sinusitis Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Drugs for Sinusitis Players to Combat Covid-19 Impact
2 Drugs for Sinusitis Estimate and Forecast by Region
2.1 Global Drugs for Sinusitis Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Drugs for Sinusitis Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Drugs for Sinusitis Sales Market Share by Region (2015-2020)
2.2.2 Global Drugs for Sinusitis Revenue Market Share by Region (2015-2020)
2.3 Global Drugs for Sinusitis Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Drugs for Sinusitis Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Drugs for Sinusitis Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Drugs for Sinusitis Estimates and Projections (2015-2026)
2.4.2 Europe Drugs for Sinusitis Estimates and Projections (2015-2026)
2.4.3 China Drugs for Sinusitis Estimates and Projections (2015-2026)
2.4.4 Japan Drugs for Sinusitis Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Drugs for Sinusitis Estimates and Projections (2015-2026)
2.4.6 India Drugs for Sinusitis Estimates and Projections (2015-2026)
3 Global Drugs for Sinusitis Competition Landscape by Players
3.1 Global Top Drugs for Sinusitis Players by Sales (2015-2020)
3.2 Global Top Drugs for Sinusitis Players by Revenue (2015-2020)
3.3 Global Drugs for Sinusitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Sinusitis as of 2019)
3.4 Global Drugs for Sinusitis Average Price by Company (2015-2020)
3.5 Manufacturers Drugs for Sinusitis Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Drugs for Sinusitis Players (Opinion Leaders)
4 Global Drugs for Sinusitis Market Size by Type
4.1 Global Drugs for Sinusitis Historic Market Review by Type (2015-2020)
4.1.1 Global Drugs for Sinusitis Sales Market Share by Type (2015-2020)
4.1.2 Global Drugs for Sinusitis Revenue Market Share by Type (2015-2020)
4.1.3 Global Drugs for Sinusitis Price by Type (2014-2020)
4.2 Global Drugs for Sinusitis Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Drugs for Sinusitis Sales Forecast by Type (2021-2026)
4.2.2 Global Drugs for Sinusitis Revenue Forecast by Type (2021-2026)
4.2.3 Global Drugs for Sinusitis Price Forecast by Type (2021-2026)
5 Global Drugs for Sinusitis Market Size by Application
5.1 Global Drugs for Sinusitis Historic Market Review by Application (2015-2020)
5.1.1 Global Drugs for Sinusitis Sales Market Share by Application (2015-2020)
5.1.2 Global Drugs for Sinusitis Revenue Market Share by Application (2015-2020)
5.1.3 Global Drugs for Sinusitis Price by Application (2015-2020)
5.2 Global Drugs for Sinusitis Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Drugs for Sinusitis Sales Forecast by Application (2021-2026)
5.2.2 Global Drugs for Sinusitis Revenue Forecast by Application (2021-2026)
5.2.3 Global Drugs for Sinusitis Price Forecast by Application (2021-2026)
3 North America Drugs for Sinusitis Market Facts & Figures
3.2 North America Drugs for Sinusitis Sales Market Share by Company (2015-2020)
3.3 North America Drugs for Sinusitis Sales Market Share by Type (2015-2020)
3.4 North America Drugs for Sinusitis Sales Market Share by Application (2015-2020)
4 Europe Drugs for Sinusitis Market Facts & Figures
4.2 Europe Drugs for Sinusitis Sales Market Share by Company (2015-2020)
4.3 Europe Drugs for Sinusitis Sales Market Share by Type (2015-2020)
4.4 Europe Drugs for Sinusitis Sales Market Share by Application (2015-2020)
5 China Drugs for Sinusitis Market Facts & Figures
5.2 China Drugs for Sinusitis Sales Market Share by Company (2015-2020)
5.3 China Drugs for Sinusitis Sales Market Share by Type (2015-2020)
5.4 China Drugs for Sinusitis Sales Market Share by Application (2015-2020)
6 Japan Drugs for Sinusitis Market Facts & Figures
6.2 Japan Drugs for Sinusitis Sales Market Share by Company (2015-2020)
6.3 Japan Drugs for Sinusitis Sales Market Share by Type (2015-2020)
6.4 Japan Drugs for Sinusitis Sales Market Share by Application (2015-2020)
7 Southeast Asia Drugs for Sinusitis Market Facts & Figures
7.2 Southeast Asia Drugs for Sinusitis Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Drugs for Sinusitis Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Drugs for Sinusitis Sales Market Share by Application (2015-2020)
8 India Drugs for Sinusitis Market Facts & Figures
8.2 India Drugs for Sinusitis Sales Market Share by Company (2015-2020)
8.3 India Drugs for Sinusitis Sales Market Share by Type (2015-2020)
8.4 India Drugs for Sinusitis Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Drugs for Sinusitis Business
12.1 Sanofi
12.1.1 Sanofi Drugs for Sinusitis Corporation Information
12.1.2 Sanofi Drugs for Sinusitis Business Overview and Total Revenue
12.1.3 Sanofi Drugs for Sinusitis Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Drugs for Sinusitis Products Offered
12.1.5 Sanofi Recent Development
12.2 Bayer AG
12.2.1 Bayer AG Drugs for Sinusitis Corporation Information
12.2.2 Bayer AG Drugs for Sinusitis Business Overview and Total Revenue
12.2.3 Bayer AG Drugs for Sinusitis Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bayer AG Drugs for Sinusitis Products Offered
12.2.5 Bayer AG Recent Development
12.3 Pfizer
12.3.1 Pfizer Drugs for Sinusitis Corporation Information
12.3.2 Pfizer Drugs for Sinusitis Business Overview and Total Revenue
12.3.3 Pfizer Drugs for Sinusitis Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Drugs for Sinusitis Products Offered
12.3.5 Pfizer Recent Development
12.4 AstraZeneca Plc
12.4.1 AstraZeneca Plc Drugs for Sinusitis Corporation Information
12.4.2 AstraZeneca Plc Drugs for Sinusitis Business Overview and Total Revenue
12.4.3 AstraZeneca Plc Drugs for Sinusitis Sales, Revenue and Gross Margin (2015-2020)
12.4.4 AstraZeneca Plc Drugs for Sinusitis Products Offered
12.4.5 AstraZeneca Plc Recent Development
12.5 Novartis AG.
12.5.1 Novartis AG. Drugs for Sinusitis Corporation Information
12.5.2 Novartis AG. Drugs for Sinusitis Business Overview and Total Revenue
12.5.3 Novartis AG. Drugs for Sinusitis Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis AG. Drugs for Sinusitis Products Offered
12.5.5 Novartis AG. Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Drugs for Sinusitis Corporation Information
12.6.2 Johnson & Johnson Drugs for Sinusitis Business Overview and Total Revenue
12.6.3 Johnson & Johnson Drugs for Sinusitis Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Johnson & Johnson Drugs for Sinusitis Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Merck
12.7.1 Merck Drugs for Sinusitis Corporation Information
12.7.2 Merck Drugs for Sinusitis Business Overview and Total Revenue
12.7.3 Merck Drugs for Sinusitis Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Merck Drugs for Sinusitis Products Offered
12.7.5 Merck Recent Development
12.8 Amgen
12.8.1 Amgen Drugs for Sinusitis Corporation Information
12.8.2 Amgen Drugs for Sinusitis Business Overview and Total Revenue
12.8.3 Amgen Drugs for Sinusitis Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Amgen Drugs for Sinusitis Products Offered
12.8.5 Amgen Recent Development
12.9 Bionorica SE
12.9.1 Bionorica SE Drugs for Sinusitis Corporation Information
12.9.2 Bionorica SE Drugs for Sinusitis Business Overview and Total Revenue
12.9.3 Bionorica SE Drugs for Sinusitis Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Bionorica SE Drugs for Sinusitis Products Offered
12.9.5 Bionorica SE Recent Development
12.10 Dr. Reddy’s Laboratories
12.10.1 Dr. Reddy’s Laboratories Drugs for Sinusitis Corporation Information
12.10.2 Dr. Reddy’s Laboratories Drugs for Sinusitis Business Overview and Total Revenue
12.10.3 Dr. Reddy’s Laboratories Drugs for Sinusitis Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Dr. Reddy’s Laboratories Drugs for Sinusitis Products Offered
12.10.5 Dr. Reddy’s Laboratories Recent Development
12.11 Huasun
12.11.1 Huasun Drugs for Sinusitis Corporation Information
12.11.2 Huasun Drugs for Sinusitis Business Overview and Total Revenue
12.11.3 Huasun Drugs for Sinusitis Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Huasun Drugs for Sinusitis Products Offered
12.11.5 Huasun Recent Development
13 Drugs for Sinusitis Manufacturing Cost Analysis
13.1 Drugs for Sinusitis Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Drugs for Sinusitis
13.4 Drugs for Sinusitis Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Drugs for Sinusitis Distributors List
14.3 Drugs for Sinusitis Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Drugs for Sinusitis Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Drugs for Sinusitis Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Drugs for Sinusitis Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Drugs for Sinusitis Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Drugs for Sinusitis Players to Combat Covid-19 Impact
Table 8. Global Market Drugs for Sinusitis Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Drugs for Sinusitis Sales (K Units) by Region (2015-2020)
Table 10. Global Drugs for Sinusitis Sales Market Share by Region (2015-2020)
Table 11. Global Drugs for Sinusitis Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Drugs for Sinusitis Revenue Share by Region (2015-2020)
Table 13. Global Drugs for Sinusitis Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Drugs for Sinusitis Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Drugs for Sinusitis Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Drugs for Sinusitis Revenue Share Forecast by Region (2021-2026)
Table 17. Global Drugs for Sinusitis (K Units) of Key Companies (2015-2020)
Table 18. Global Drugs for Sinusitis Sales Share by Company (2015-2020)
Table 19. Global Drugs for Sinusitis Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Drugs for Sinusitis Revenue Share by Company (2015-2020)
Table 21. Global Drugs for Sinusitis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Sinusitis as of 2019)
Table 22. Global Drugs for Sinusitis Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Drugs for Sinusitis Manufacturing Sites and Area Served
Table 24. Manufacturers Drugs for Sinusitis Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Drugs for Sinusitis Players
Table 27. Global Drugs for Sinusitis Sales (K Units) by Type (2015-2020)
Table 28. Global Drugs for Sinusitis Sales Share by Type (2015-2020)
Table 29. Global Drugs for Sinusitis Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Drugs for Sinusitis Price (K Units) by Type (2015-2020)
Table 31. Global Drugs for Sinusitis Sales Share by Type (2021-2026)
Table 32. Global Drugs for Sinusitis Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Drugs for Sinusitis Revenue Share by Type (2021-2026)
Table 34. Global Drugs for Sinusitis Price (K Units) by Type (2021-2026)
Table 35. Global Drugs for Sinusitis Sales (K Units) by Application (2015-2020)
Table 36. Global Drugs for Sinusitis Sales Share by Application (2015-2020)
Table 37. Global Drugs for Sinusitis Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Drugs for Sinusitis Price (K Units) by Application (2015-2020)
Table 39. Global Drugs for Sinusitis Sales (K Units) by Application (2021-2026)
Table 40. Global Drugs for Sinusitis Sales Share by Application (2021-2026)
Table 41. Global Drugs for Sinusitis Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Drugs for Sinusitis Revenue Share by Application (2021-2026)
Table 43. Global Drugs for Sinusitis Price (K Units) by Application (2021-2026)
Table 44. United States Drugs for Sinusitis Sales (K Units) by Company (2015-2020)
Table 45. United States Drugs for Sinusitis Sales Market Share by Company (2015-2020)
Table 46. United States Drugs for Sinusitis Sales (K Units) by Type (2015-2020)
Table 47. United States Drugs for Sinusitis Sales Market Share by Type (2015-2020)
Table 48. United States Drugs for Sinusitis Sales (K Units) by Application (2015-2020)
Table 49. United States Drugs for Sinusitis Sales Market Share by Application (2015-2020)
Table 50. Europe Drugs for Sinusitis Sales (K Units) by Company (2015-2020)
Table 51. Europe Drugs for Sinusitis Sales Market Share by Company (2015-2020)
Table 52. Europe Drugs for Sinusitis Sales (K Units) by Type (2015-2020)
Table 53. Europe Drugs for Sinusitis Sales Market Share by Type (2015-2020)
Table 54. Europe Drugs for Sinusitis Sales (K Units) by Application (2015-2020)
Table 55. Europe Drugs for Sinusitis Sales Market Share by Type (2015-2020)
Table 56. China Drugs for Sinusitis Sales (K Units) by Company (2015-2020)
Table 57. China Drugs for Sinusitis Sales Market Share by Company (2015-2020)
Table 58. China Drugs for Sinusitis Sales (K Units) by Type (2015-2020)
Table 59. China Drugs for Sinusitis Sales Market Share by Type (2015-2020)
Table 60. China Drugs for Sinusitis Sales (K Units) by Application (2015-2020)
Table 61. China Drugs for Sinusitis Sales Market Share by Application (2015-2020)
Table 62. Japan Drugs for Sinusitis Sales (K Units) by Company (2015-2020)
Table 63. Japan Drugs for Sinusitis Sales Market Share by Company (2015-2020)
Table 64. Japan Drugs for Sinusitis Sales (K Units) by Type (2015-2020)
Table 65. Japan Drugs for Sinusitis Sales Market Share by Type (2015-2020)
Table 66. Japan Drugs for Sinusitis Sales (K Units) by Application (2015-2020)
Table 67. Japan Drugs for Sinusitis Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Drugs for Sinusitis Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Drugs for Sinusitis Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Drugs for Sinusitis Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Drugs for Sinusitis Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Drugs for Sinusitis Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Drugs for Sinusitis Sales Market Share by Application (2015-2020)
Table 74. India Drugs for Sinusitis Sales (K Units) by Company (2015-2020)
Table 75. India Drugs for Sinusitis Sales Market Share by Company (2015-2020)
Table 76. India Drugs for Sinusitis Sales (K Units) by Type (2015-2020)
Table 77. India Drugs for Sinusitis Sales Market Share by Type (2015-2020)
Table 78. India Drugs for Sinusitis Sales (K Units) by Application (2015-2020)
Table 79. India Drugs for Sinusitis Sales Market Share by Application (2015-2020)
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Drugs for Sinusitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Sanofi Drugs for Sinusitis Product
Table 84. Sanofi Recent Development
Table 85. Bayer AG Corporation Information
Table 86. Bayer AG Description and Business Overview
Table 87. Bayer AG Drugs for Sinusitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Bayer AG Drugs for Sinusitis Product
Table 89. Bayer AG Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Drugs for Sinusitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Pfizer Drugs for Sinusitis Product
Table 94. Pfizer Recent Development
Table 95. AstraZeneca Plc Corporation Information
Table 96. AstraZeneca Plc Description and Business Overview
Table 97. AstraZeneca Plc Drugs for Sinusitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. AstraZeneca Plc Drugs for Sinusitis Product
Table 99. AstraZeneca Plc Recent Development
Table 100. Novartis AG. Corporation Information
Table 101. Novartis AG. Description and Business Overview
Table 102. Novartis AG. Drugs for Sinusitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Novartis AG. Drugs for Sinusitis Product
Table 104. Novartis AG. Recent Development
Table 105. Johnson & Johnson Corporation Information
Table 106. Johnson & Johnson Description and Business Overview
Table 107. Johnson & Johnson Drugs for Sinusitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Johnson & Johnson Drugs for Sinusitis Product
Table 109. Johnson & Johnson Recent Development
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Drugs for Sinusitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Merck Drugs for Sinusitis Product
Table 114. Merck Recent Development
Table 115. Amgen Corporation Information
Table 116. Amgen Drugs for Sinusitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Amgen Description and Business Overview
Table 118. Amgen Drugs for Sinusitis Product
Table 119. Amgen Recent Development
Table 120. Bionorica SE Corporation Information
Table 121. Bionorica SE Drugs for Sinusitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Bionorica SE Description and Business Overview
Table 123. Bionorica SE Drugs for Sinusitis Product
Table 124. Bionorica SE Recent Development
Table 125. Dr. Reddy's Laboratories Corporation Information
Table 126. Dr. Reddy's Laboratories Description and Business Overview
Table 127. Dr. Reddy's Laboratories Drugs for Sinusitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Dr. Reddy's Laboratories Drugs for Sinusitis Product
Table 129. Dr. Reddy's Laboratories Recent Development
Table . Huasun Corporation Information
Table . Huasun Description and Business Overview
Table . Huasun Drugs for Sinusitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Huasun Drugs for Sinusitis Product
Table . Huasun Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Drugs for Sinusitis Distributors List
Table 138. Drugs for Sinusitis Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Sinusitis Product Picture
Figure 2. Global Drugs for Sinusitis Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Drugs for Sinusitis Market Share by Application in 2020 & 2026
Figure 6. Acute Sinusitis Examples
Figure 7. Chronic Sinusitis Examples
Figure 8. Global Drugs for Sinusitis Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Drugs for Sinusitis Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Drugs for Sinusitis Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Drugs for Sinusitis Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Drugs for Sinusitis Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Drugs for Sinusitis Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Drugs for Sinusitis Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Drugs for Sinusitis Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Drugs for Sinusitis Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Drugs for Sinusitis Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Drugs for Sinusitis Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Drugs for Sinusitis Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Drugs for Sinusitis Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Drugs for Sinusitis Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Drugs for Sinusitis Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Drugs for Sinusitis Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Drugs for Sinusitis Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Drugs for Sinusitis Players Market Share by Revenue in Drugs for Sinusitis 2015 & 2019
Figure 26. Drugs for Sinusitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Drugs for Sinusitis Revenue Share by Type (2015-2020)
Figure 28. Global Drugs for Sinusitis Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Drugs for Sinusitis Revenue Share by Application (2015-2020)
Figure 30. Global Drugs for Sinusitis Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Drugs for Sinusitis Sales Market Share by Type in 2019
Figure 32. United States Drugs for Sinusitis Sales Market Share by Type in 2019
Figure 33. Europe Drugs for Sinusitis Sales Market Share by Company in 2019
Figure 34. Europe Drugs for Sinusitis Sales Market Share by Type in 2019
Figure 35. Europe Drugs for Sinusitis Sales Market Share by Application in 2019
Figure 36. China Drugs for Sinusitis Sales Market Share by Company in 2019
Figure 37. China Drugs for Sinusitis Sales Market Share by Type in 2019
Figure 38. China Drugs for Sinusitis Sales Market Share by Application in 2019
Figure 39. Japan Drugs for Sinusitis Sales Market Share by Company in 2019
Figure 40. Japan Drugs for Sinusitis Sales Market Share by Type in 2019
Figure 41. Japan Drugs for Sinusitis Sales Market Share by Application in 2019
Figure 42. Southeast Asia Drugs for Sinusitis Sales Market Share by Company in 2019
Figure 43. Southeast Asia Drugs for Sinusitis Sales Market Share by Type in 2019
Figure 44. Southeast Asia Drugs for Sinusitis Sales Market Share by Application in 2019
Figure 45. India Drugs for Sinusitis Sales Market Share by Company in 2019
Figure 46. India Drugs for Sinusitis Sales Market Share by Type in 2019
Figure 47. India Drugs for Sinusitis Sales Market Share by Application in 2019
Figure 48. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. AstraZeneca Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Novartis AG. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Bionorica SE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Dr. Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Huasun Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Drugs for Sinusitis
Figure 61. Manufacturing Process Analysis of Drugs for Sinusitis
Figure 62. Drugs for Sinusitis Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
副鼻腔炎薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Sinusitis Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sinusitis Drugs market report…- 副鼻腔炎治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Sinusitis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sinusitis Treatment marke…
- エクセナチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Exenatide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate da…
- リラグルチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Liraglutide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …
- 内分泌系薬の世界市場レポート2020 Market Analysis and Insights: Global Endocrine System Drugs Market The global Endocrine System Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Endocrine System Drugs Scope and Market Size The global…